Amalgamated Bank’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
P
LCM
TCM
PAI
6CM
Amalgamated Bank's PYXS Position: Q2 2025 in Review
Amalgamated Bank sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 1,690 shares — an estimated $2K sold.
Amalgamated Bank first reported a position in PYXS in Q1 2022 and held it in 5 quarters. The position peaked at $6K in Q3 2024. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.
- Amalgamated Bank reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
- Amalgamated Bank sold 1,690 Pyxis Oncology shares in Q2 2025, an estimated $2K.
- Amalgamated Bank first reported a position in Pyxis Oncology in Q1 2022 and held it in 5 quarters.
- Amalgamated Bank's Pyxis Oncology position peaked at $6K in Q3 2024.
- 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.
Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.